HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Cornelis Ja Punt Selected Research
Cornelis Ja Punt Research Topics
Disease
4
Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 07/2007
3
Neoplasms (Cancer)
01/2021 - 06/2013
2
Melanoma (Melanoma, Malignant)
08/2015 - 07/2008
1
Neoplasm Metastasis (Metastasis)
01/2021
1
Colonic Neoplasms (Colon Cancer)
01/2019
1
Macular Degeneration (Age-Related Maculopathy)
10/2017
1
Rectal Neoplasms (Rectal Cancer)
01/2015
1
Fatigue
07/2008
Drug/Important Bio-Agent (IBA)
2
Biomarkers (Surrogate Marker)
IBA
01/2021 - 01/2015
2
Oxaliplatin (Eloxatin)
FDA Link
Generic
10/2017 - 07/2007
2
Capecitabine (Xeloda)
FDA Link
10/2017 - 07/2007
1
Cell-Free Nucleic Acids
IBA
01/2021
1
pegaptanib (Macugen)
FDA Link
10/2017
1
Cetuximab (Erbitux)
FDA Link
10/2017
1
Bevacizumab (Avastin)
FDA Link
10/2017
1
CD40 Ligand (CD40L)
IBA
08/2015
1
Antigens
IBA
08/2015
1
Messenger RNA (mRNA)
IBA
08/2015
1
Monophenol Monooxygenase (Tyrosinase)
IBA
08/2015
1
Interferon alpha-2 (Roferon-A)
FDA Link
07/2008
1
Interferons
IBA
07/2008
1
peginterferon alfa-2b (Pegintron)
FDA Link
07/2008
1
Irinotecan (Camptosar)
FDA Link
Generic
07/2007
Therapy/Procedure
2
Therapeutics
08/2015 - 07/2008
2
Immunotherapy
08/2015 - 06/2013
1
Adjuvant Chemotherapy
01/2019
1
Duration of Therapy
07/2008
1
Combination Drug Therapy (Combination Chemotherapy)
07/2007